GAMMA Investing’s AbbVie ABBV Stock Holding History

GAMMA Investing’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$19.6M	Buy	75,060 +7,058	+10%	+$1.81M	0.66%	21
2026 Q2	$17.1M	Buy	68,002 +5,149	+8%	+$1.11M	0.64%	23
2026 Q1	$13.7M	Buy	62,853 +2,118	+3%	+$470K	0.64%	21
2025 Q4	$13.9M	Buy	60,735 +3,576	+6%	+$815K	0.7%	19
2025 Q3	$13.2M	Buy	57,159 +4,633	+9%	+$943K	0.73%	17
2025 Q2	$9.7M	Buy	52,526 +3,678	+8%	+$684K	0.62%	21
2025 Q1	$10.2M	Buy	48,848 +9,395	+24%	+$1.83M	0.77%	17
2024 Q4	$7.01M	Buy	39,453 +3,439	+10%	+$632K	0.6%	23
2024 Q3	$7.11M	Buy	36,014 +8,014	+29%	+$1.5M	0.71%	19
2024 Q2	$4.8M	Buy	28,000 +8,640	+45%	+$1.43M	0.65%	20
2024 Q1	$3.53M	Buy	19,360 +3,083	+19%	+$531K	0.72%	19
2023 Q4	$2.68M	Buy	+16,277	New	+$2.37M	0.72%	20

Other funds holding ABBV

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Cardano Risk Management Rotterdam, Netherlands $18.2B AUM 38.97% 1-Year Est. Return

Sepio Capital Salt Lake City, Utah $2.5B AUM 20.77% 1-Year Est. Return

Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return

ABN AMRO Investment Solutions Paris Cedex 008 $13.2B AUM 30.55% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

GAMMA Investing's ABBV Position: Q3 2026 in Review

GAMMA Investing increased its AbbVie (ABBV) stake by 10% in Q3 2026, buying an estimated $1.81M and bringing the position to 75,060 shares worth $19.6M. The position accounts for 0.66% of the portfolio, ranked #21.

GAMMA Investing first reported a position in ABBV in Q4 2023 and has held it in 12 quarters since. 1,436 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

GAMMA Investing held 75,060 shares of AbbVie worth $19.6M as of Q3 2026.
GAMMA Investing bought 7,058 AbbVie shares in Q3 2026, an estimated $1.81M.
AbbVie made up 0.66% of GAMMA Investing's portfolio in Q3 2026, its #21 holding.
GAMMA Investing first reported a position in AbbVie in Q4 2023 and has held it in 12 quarters since.
1,436 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.